Skip to main content
What types of page to search?

Alternatively use our A-Z index.

Dr Kukatharmini Tharmaratnam
PhD

Contact

K.Tharmaratnam@liverpool.ac.uk

+44 (0)151 794 9724

Research outputs

What type of research output do you want to show?

2025

Abstract P3-12-24: PREMO CNS: PREsentation, Management and Outcomes of patients with CNS disease secondary to breast cancer in England

Bhogal, T., Tharmaratnam, K., Cheyne, C., Leeming, G., Garcia-Finana, M., & Palmieri, C. (2025). Abstract P3-12-24: PREMO CNS: PREsentation, Management and Outcomes of patients with CNS disease secondary to breast cancer in England. Clinical Cancer Research, 31(12_Supplement). doi:10.1158/1557-3265.sabcs24-p3-12-24

DOI
10.1158/1557-3265.sabcs24-p3-12-24
Journal article

P297 The presence of oral bacterial pathobionts and their volatile organic compound markers in the stool of colorectal cancer patients

Slater, R., Frau, A., Ijaz, U. Z., Green, K., Tharmaratnam, K., Lofthouse, M., . . . Probert, C. (2025). P297 The presence of oral bacterial pathobionts and their volatile organic compound markers in the stool of colorectal cancer patients. In Posters (pp. A270.2-A271). BMJ Publishing Group Ltd and British Society of Gastroenterology. doi:10.1136/gutjnl-2025-bsg.430

DOI
10.1136/gutjnl-2025-bsg.430
Conference Paper

P298 A volatile organic compound, clinical variable and faecal immunochemical test model for the detection of malignant and pre-malignant colorectal neoplasia

Slater, R., Tharmaratnam, K., Green, K., Frau, A., Lofthouse, M., Hold, G., . . . Probert, C. (2025). P298 A volatile organic compound, clinical variable and faecal immunochemical test model for the detection of malignant and pre-malignant colorectal neoplasia. In Posters (pp. A271). BMJ Publishing Group Ltd and British Society of Gastroenterology. doi:10.1136/gutjnl-2025-bsg.431

DOI
10.1136/gutjnl-2025-bsg.431
Conference Paper

Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients.

Sarker, C., Jorgensen, A. L., Tharmaratnam, K., Al-Abadi, E., Armon, K., Bailey, K., . . . Smith, E. M. D. (2025). Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients.. Rheumatology (Oxford, England), 64(6), 3587-3597. doi:10.1093/rheumatology/keaf057

DOI
10.1093/rheumatology/keaf057
Journal article

16 Can we "smell" something important?

Cornford, P., Dawson, J., Yassaie, O., Lazarowicz, H., Tharmaratnam, K., Garyia-Finana, M., & Probert, C. (2025). 16 Can we "smell" something important?. European Urology Open Science, 71, S18. doi:10.1016/s2666-1683(25)00019-9

DOI
10.1016/s2666-1683(25)00019-9
Journal article

Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction.

Wood, G. K., Sargent, B. F., Ahmad, Z. -U. -A., Tharmaratnam, K., Dunai, C., Egbe, F. N., . . . Leek, E. C. (2024). Post-hospitalisation COVID-19 cognitive deficits at one year are global and associated with elevated brain injury markers and grey matter volume reduction.. Nature medicine. doi:10.1038/s41591-024-03309-8

DOI
10.1038/s41591-024-03309-8
Journal article

2024

Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.

Belnour, S., Slater, R., Tharmaratnam, K., Karl-Heinz Auth, M., Muhammed, R., Spray, C., . . . Allen, S. (2024). Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.. United European gastroenterology journal, 12(6), 780-792. doi:10.1002/ueg2.12603

DOI
10.1002/ueg2.12603
Journal article

P109 Faecal volatile organic compound detection using a gas chromatography sensor to diagnose inflammatory bowel disease in a paediatric inception cohort

Slater, R., Tharmaratnam, K., Belnour, S., Auth, M., Muhammed, R., Spray, C., . . . Probert, C. (2024). P109 Faecal volatile organic compound detection using a gas chromatography sensor to diagnose inflammatory bowel disease in a paediatric inception cohort. In Poster Presentations (pp. A116.1-A116). BMJ Publishing Group Ltd and British Society of Gastroenterology. doi:10.1136/gutjnl-2024-bsg.191

DOI
10.1136/gutjnl-2024-bsg.191
Conference Paper

Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.

Michael, B. D., Dunai, C., Needham, E. J., Tharmaratnam, K., Williams, R., Huang, Y., . . . Menon, D. K. (2024). Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.. Nature communications, 15(1), 2918. doi:10.1038/s41467-024-47320-6

DOI
10.1038/s41467-024-47320-6
Journal article

Lower than expected? Establishing a PSA density threshold

Dawson, J., Yassaie, O., Tharmaratnam, K., Garcia-Finana, M., Probert, C., Lazarowicz, H. P., & Cornford, P. A. (2024). Lower than expected? Establishing a PSA density threshold. European Urology, 85, S1689. doi:10.1016/s0302-2838(24)01294-6

DOI
10.1016/s0302-2838(24)01294-6
Journal article

COVID-19 risk-mitigation in reopening mass cultural events: population-based observational study for the UK Events Research Programme in Liverpool City Region

Burnside, G., Cheyne, C. P., Leeming, G., Humann, M., Darby, A., Green, M. A., . . . Buchan, I. E. (2024). COVID-19 risk-mitigation in reopening mass cultural events: population-based observational study for the UK Events Research Programme in Liverpool City Region. Journal of the Royal Society of Medicine. doi:10.1177/01410768231182389

DOI
10.1177/01410768231182389
Journal article

2023

Scientific Business Abstracts

Siew, K., Patel, V., Zimmermann, J., Vaughan, M., Cheshire, C., Kubik, A., . . . Leek, C. (2023). Scientific Business Abstracts. QJM: An International Journal of Medicine. doi:10.1093/qjmed/hcad072

DOI
10.1093/qjmed/hcad072
Journal article

A Novel Filter and Embedded Feature Selection Methods applied to High Dimensional Metabolomics Data in Enhancing Colorectal Cancer Classification

DOI
10.21203/rs.3.rs-2905357/v1
Preprint

2022

Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease

Soares, M. V., Gomez, V. E., Azevedo, R. I., Pereira, P. N. G., Velazquez, T. C., Garcia-Calderon, C. B., . . . Lacerda, J. F. (2022). Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease. In BLOOD Vol. 140. doi:10.1182/blood-2022-163394

DOI
10.1182/blood-2022-163394
Conference Paper

Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts

Wood, G. K., Babar, R., Ellul, M. A., Thomas, R. H., Van Den Tooren, H., Easton, A., . . . Michael, B. D. (2022). Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts. BMJ Neurology Open, 4(2), e000323. doi:10.1136/bmjno-2022-000323

DOI
10.1136/bmjno-2022-000323
Journal article

2021

THE UTILITY OF ESTABLISHED PROGNOSTIC SCORES IN COVID-19 HOSPITAL ADMISSIONS: A COLLABORATIVE TRAINEE-LED, MULTI-CENTRE PROSPECTIVE EVALUATION OF CURB-65, NEWS2, AND QSOFA

Frost, F., Bradley, P., Tharmaratnam, K., & Wootton, D. (2021). THE UTILITY OF ESTABLISHED PROGNOSTIC SCORES IN COVID-19 HOSPITAL ADMISSIONS: A COLLABORATIVE TRAINEE-LED, MULTI-CENTRE PROSPECTIVE EVALUATION OF CURB-65, NEWS2, AND QSOFA. In THORAX Vol. 76 (pp. A57-A58). doi:10.1136/thorax-2020-BTSabstracts.100

DOI
10.1136/thorax-2020-BTSabstracts.100
Conference Paper

2020

2018

Cancer risk and survival in <i>path</i>_<i>MMR</i> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database

Moller, P., Seppala, T. T., Bernstein, I., Holinski-Feder, E., Sala, P., Evans, D. G., . . . Capella, G. (2018). Cancer risk and survival in <i>path</i>_<i>MMR</i> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. GUT, 67(7), 1306-1316. doi:10.1136/gutjnl-2017-314057

DOI
10.1136/gutjnl-2017-314057
Journal article

Identification of predicted individual treatment effects in randomized clinical trials

Lamont, A., Lyons, M. D., Jaki, T., Stuart, E., Feaster, D. J., Tharmaratnam, K., . . . Van Horn, M. L. (2018). Identification of predicted individual treatment effects in randomized clinical trials. STATISTICAL METHODS IN MEDICAL RESEARCH, 27(1), 142-157. doi:10.1177/0962280215623981

DOI
10.1177/0962280215623981
Journal article

2017

Colorectal cancer incidence in <i>path_MLH1</i> carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report

Seppala, T., Pylvanainen, K., Evans, D. G., Jarvinen, H., Renkonen-Sinisalo, L., Bernstein, I., . . . Moller, P. (2017). Colorectal cancer incidence in <i>path_MLH1</i> carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report. HEREDITARY CANCER IN CLINICAL PRACTICE, 15. doi:10.1186/s13053-017-0078-5

DOI
10.1186/s13053-017-0078-5
Journal article

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database

Moller, P., Seppala, T., Bernstein, I., Holinski-Feder, E., Sala, P., Evans, D. G., . . . Capella, G. (2017). Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database. GUT, 66(9), 1657-1664. doi:10.1136/gutjnl-2016-311403

DOI
10.1136/gutjnl-2016-311403
Journal article

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database

Moller, P., Seppala, T., Bernstein, I., Holinski-Feder, E., Sala, P., Evans, D. G., . . . Moslein, G. (2017). Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. GUT, 66(3), 464-472. doi:10.1136/gutjnl-2015-309675

DOI
10.1136/gutjnl-2015-309675
Journal article

Point and interval estimation for predicting individual patients treatment effect based on randomized clinical trial data

Tharmaratnam, K., & Jaki, T. (2017). Point and interval estimation for predicting individual patients treatment effect based on randomized clinical trial data. In TRIALS Vol. 18. Retrieved from https://www.webofscience.com/

Conference Paper

2016

Tilting the lasso by knowledge-based post-processing

Tharmaratnam, K., Sperrin, M., Jaki, T., Reppe, S., & Frigessi, A. (2016). Tilting the lasso by knowledge-based post-processing. BMC BIOINFORMATICS, 17. doi:10.1186/s12859-016-1210-7

DOI
10.1186/s12859-016-1210-7
Journal article

Intensive breast screening in <i>BRCA2</i> mutation carriers is associated with reduced breast cancer specific and all cause mortality

Evans, D. G., Harkness, E. F., Howell, A., Wilson, M., Hurley, E., Holmen, M. M., . . . Moller, P. (2016). Intensive breast screening in <i>BRCA2</i> mutation carriers is associated with reduced breast cancer specific and all cause mortality. HEREDITARY CANCER IN CLINICAL PRACTICE, 14. doi:10.1186/s13053-016-0048-3

DOI
10.1186/s13053-016-0048-3
Journal article

2015

Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography

Moller, P., Tharmaratnam, K., Howell, A., Stavrinos, P., Sampson, S., Wallace, A., . . . Evans, D. G. (2015). Tumour characteristics and survival in familial breast cancer prospectively diagnosed by annual mammography. BREAST CANCER RESEARCH AND TREATMENT, 152(1), 87-94. doi:10.1007/s10549-015-3448-6

DOI
10.1007/s10549-015-3448-6
Journal article

Ten modifiers of <i>BRCA1</i> penetrance validated in a Norwegian series

Heramb, C., Ekstrom, P. O., Tharmaratnam, K., Hovig, E., Moller, P., & Maehle, L. (2015). Ten modifiers of <i>BRCA1</i> penetrance validated in a Norwegian series. HEREDITARY CANCER IN CLINICAL PRACTICE, 13. doi:10.1186/s13053-015-0035-0

DOI
10.1186/s13053-015-0035-0
Journal article

Regression

Glad, I. K., & Tharmaratnam, K. (2015). Regression. In Encyclopedia of Applied and Computational Mathematics (pp. 1225-1233). Springer Berlin Heidelberg. doi:10.1007/978-3-540-70529-1_420

DOI
10.1007/978-3-540-70529-1_420
Chapter

2014

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis

Tharmaratnam, K., Hagen, A. I., & Moller, P. (2014). MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis. BREAST CANCER RESEARCH AND TREATMENT, 148(3), 687-688. doi:10.1007/s10549-014-3178-1

DOI
10.1007/s10549-014-3178-1
Journal article

2013

Monotone splines lasso

Bergersen, L. C., Tharmaratnam, K., & Glad, I. K. (2014). Monotone splines lasso. COMPUTATIONAL STATISTICS & DATA ANALYSIS, 77, 336-351. doi:10.1016/j.csda.2014.03.013

DOI
10.1016/j.csda.2014.03.013
Journal article

A comparison of robust versions of the AIC based on M-, S- and MM-estimators

Tharmaratnam, K., & Claeskens, G. (2013). A comparison of robust versions of the AIC based on M-, S- and MM-estimators. Statistics, 47(1), 216-235. doi:10.1080/02331888.2011.568120

DOI
10.1080/02331888.2011.568120
Journal article

2011

S-Estimation and a Robust Conditional Akaike Information Criterion for Linear Mixed Models

Tharmaratnam, K., & Claeskens, G. (2011). S-Estimation and a Robust Conditional Akaike Information Criterion for Linear Mixed Models.

Journal article

2010

S-Estimation for Penalized Regression Splines

Tharmaratnam, K., Claeskens, G., Croux, C., & Salibián-Barrera, M. (2010). S-Estimation for Penalized Regression Splines. Journal of Computational and Graphical Statistics, 19(3), 609-625. doi:10.1198/jcgs.2010.08149

DOI
10.1198/jcgs.2010.08149
Journal article